- ►ahajournals.org AH Berg, PE Scherer - Circulation Research, 2005 - Am Heart Assoc Mounting evidence highlights the role of adipose tissue in the development of a
systemic inflammatory state that contributes to obesity-associated vasculopathy
and cardiovascular risk. Circulating mediators of inflammation participate ... Cited by 422 - Related articles - All 10 versions
TD Wang, WJ Chen, JW Lin, MF Chen, YT … - The American journal of cardiology, 2004 - Elsevier Fifty nondiabetic patients who met a modified National Cholesterol Education
Program definition for the metabolic syndrome were randomized to receive either
rosiglitazone (4 mg/day; N = 25) or placebo (n = 25) for 8 weeks. Compared ... Cited by 151 - Related articles - All 10 versions
- ►infodiabetes.it [PDF] PD Home, SJ Pocock, H Beck-Nielsen, R … - Diabetologia, 2005 - Springer Page 1. Diabetologia (2005) 48: 1726–1735 DOI 10.1007/s00125-005-1869-1 ARTICLE
PD Home . SJ Pocock . H. Beck-Nielsen . R. Gomis . M. Hanefeld . H. Dargie . ... Cited by 147 - Related articles - BL Direct - All 5 versions
MA Gonzalez, AP Selwyn - The American journal of medicine, 2003 - Elsevier Endothelial dysfunction may be evaluated by means of invasive techniques, such
as coronary artery reactivity to acetylcholine, or noninvasive techniques, such
as brachial artery ultrasonography. Loss of endothelium-dependent ... Cited by 124 - Related articles - All 9 versions
- ►endojournals.org KM Utzschneider, SE Kahn - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Evidence Synthesis: Insulin resistance in NAFLD is characterized by reductions
in whole-body, hepatic, and adipose tissue insulin sensitivity. The mechanisms
underlying the accumulation of fat in the liver may include excess dietary ... Cited by 114 - Related articles - BL Direct - All 4 versions
M Rattazzi, M Puato, E Faggin, B Bertipaglia, … - Journal of hypertension, 2003 - journals.lww.com Recent advances in basic science have shown that atherosclerosis should be
considered as a chronic inflammatory process, and that a pivotal role of
inflammation is evident from initiation through progression and ... Cited by 106 - Related articles - BL Direct - All 7 versions
- ►asnjournals.org FA El-Atat, SN Stas, SI McFarlane, JR Sowers - Journal of the American Society of Nephrology, 2004 - Am Soc Nephrol The incidence of end-stage renal disease (ESRD) has risen dramatically in the
past decade, mainly due to the increasing prevalence of diabetes mellitus, and
both impaired glucose tolerance and hypertension are important contributors ... Cited by 90 - Related articles - BL Direct - All 5 versions
C Vitale, G Mercuro, C Castiglioni, A Cornoldi, … - Cardiovascular Diabetology, 2005 - cardiab.com Metabolic syndrome is a cluster of common cardiovascular risk factors that
includes hypertension and insulin resistance. Hypertension and diabetes mellitus
are frequent comorbidities and, like metabolic syndrome, increase the risk ... Cited by 85 - Related articles - Cached - All 12 versions
R Nesto - Diabetic medicine, 2004 - pt.wkhealth.com Increased concentrations of the marker of inflammation, C-reactive protein
(CRP), are associated with insulin resistance, Type 2 diabetes and the
development of cardiovascular disease. In particular, inflammation is ... Cited by 83 - Related articles - BL Direct - All 7 versions
K Prasad - Cardiovascular drug reviews, 2006 - interscience.wiley.com C-reactive protein (CRP) plays a role in the pathogenesis of cardiovascular
disease. It is a marker and predictor of cardiovascular disease. CRP possesses
numerous cardiovascular effects (clotting, generation of oxygen radicals, ... Cited by 79 - Related articles - BL Direct - All 5 versions
